Skip to main content
IntroMedic Co., Ltd. logo

IntroMedic Co., Ltd. — Investor Relations & Filings

Ticker · 150840 ISIN · KR7150840007 KO Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2021-03-10 Proxy Solicitation & In…
Country KR South Korea
Listing KO 150840

About IntroMedic Co., Ltd.

http://www.intromedic.com/

IntroMedic Co., Ltd. is a medical device company that develops, manufactures, and distributes capsule endoscopy products. Established in 2004, the company's core offering is the MiroCam® capsule endoscope system. This system is designed as a tool for the detection of abnormalities within the small bowel in both adult and pediatric patients from two years of age. IntroMedic operates through a global network of partner companies to distribute its medical equipment.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document), which is a standard regulatory filing in South Korea used to solicit proxies from shareholders for an upcoming Annual General Meeting (AGM). It contains information about the meeting date, the purpose of the meeting, and the proxy solicitation process. While it includes financial statements, these are provided as reference material for the shareholders to review before voting, which is a standard requirement for proxy solicitation documents. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2021-03-10 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and provides the outcome of a shareholder vote (approval of agenda items). This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-02-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (IntroMedic) disclosing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for listed companies to report preliminary financial results before the final audit. Since it provides key financial highlights and performance metrics rather than a full annual report or a simple announcement of a report's availability, it falls under the category of Earnings Release (ER). FY 2020
2021-02-05 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Intromedic. It outlines the date, time, location, and the agenda items (such as financial statement approval, director/auditor appointments, and remuneration limits). This document is a standard proxy solicitation material used to inform shareholders of an upcoming meeting and the matters to be voted upon, which fits the definition of Proxy Solicitation & Information Statement (PSI).
2021-02-05 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from Intromedic regarding a change in the location and time of an Extraordinary General Meeting (EGM). It is a 'Correction Report' (정정신고) for a previously filed 'Resolution to Convene a General Meeting of Shareholders' (주주총회소집결의). Since this document provides specific details regarding the meeting logistics and agenda items (such as business purpose changes) for an upcoming shareholder meeting, it falls under the category of Proxy Solicitation & Information Statement (PSI), as it serves to inform shareholders of the meeting details and agenda.
2021-02-01 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a '주주총회소집공고' (Notice of General Meeting of Shareholders) for an Extraordinary General Meeting (임시주주총회). It includes details such as the meeting date, location, agenda items (e.g., partial amendment of articles of incorporation), and management information (e.g., director activities, business overview). This type of document is a formal communication to shareholders regarding an upcoming meeting and is classified as a Proxy Solicitation & Information Statement.
2021-02-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.